Stephen P. MacMillan

Stephen P. MacMillan is the chairman, president and chief executive officer of Hologic, a medical device and diagnostic manufacturer headquartered in Marlborough, Massachusetts. Former CEO of Stryker Corporation, a medical device manufacturer headquartered in Kalamazoo, Michigan.
Education.
MacMillan received a B.A degree in Economics from Davidson College, where he was co-captain of the golf team. He is also a graduate of Harvard Business School's Advanced Management Program. MacMillan serves on the Davidson College Board of Trustees.
Career.
 Stephen P. MacMillan is the chairman, president, and chief executive officer, and director of Hologic, a medical device and diagnostic manufacturer headquartered in Marlborough, Massachusetts. Hologic is a world leader in innovative medical technology primarily focused on improving women’s health through early detection and treatment. He was previously the chairman of the board, president, and chief executive officer of Stryker Corporation, a global medical device company, and has 30 years of healthcare industry operating experience. He served as chief executive officer of Stryker from January 2005 to February 2012 and served as its president from June 2003 to February 2012. During his tenure at Stryker, MacMillan successfully led the company through a series of key strategic acquisitions, the launch of a number of products within the orthopedic implants and medical instrumentation businesses, and delivered strong operating performance, with revenue growing from $2.8 billion to $8.3 billion, between 2003 and 2011. During his tenure, Stryker delivered stock price appreciation of more than 62%, compared to appreciation of the S&P 500 index of approximately 40%. While MacMillan presided as CEO, Stryker was selected by FORTUNE, over multiple consecutive years, as one of the "World's Most Admired Companies" in the medical equipment industry.
Prior to Stryker, MacMillan was a senior executive at Pharmacia Corporation, a global pharmaceutical company, where he oversaw five global businesses with revenue exceeding $2 billion, including one in diagnostics. MacMillan began his career with Procter & Gamble in 1985 and later spent 11 years with Johnson & Johnson in both the U.S. and Europe, and became president of the joint venture between Johnson & Johnson and Merck.
In 2010, MacMillan was appointed by the U.S. Commerce Secretary to a two-year term on the U.S. Manufacturing Council, a group which advised the administration on ideas to create more U.S. manufacturing jobs.
On February 8, 2012, MacMillan resigned from Stryker.In November 2012, he was named CEO of sBiomed, a Utah-based company.
On December 9, 2013, MacMillan was named president and chief executive officer of Hologic. He also joined Hologic's board.
On April 1, 2015, Boston Scientific appointed MacMillan to its board.
MacMillan has served on the boards of directors at several companies, including Texas Instruments, Alere, the Greater Kalamazoo United Way and AdvaMed. He was also a member of the Institute of Medicine's Roundtable on Value & Science-Driven Health Care.
Compensation.
On May 17, 2015, The New York Times reported that MacMillan received a pay package totaling $24.5 million in 2014.
March 2019, The Wall Street Journal reported that MacMillan received a $42 million pay package.